Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07118176) titled 'Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers' on Aug. 5.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Jonsson Comprehensive Cancer Center
Condition:
Anal Carcinoma
Bladder Carcinoma
Breast Carcinoma
Cervical Carcinoma
Cholangiocarcinoma
Colorectal Carcinoma
Esophageal Carcinoma
Gastric Carcinoma
Head and Neck Carcinoma
Hematopoietic and Lymphatic System Neoplasm
Hepatocellular Carcinoma
Lung Carcinoma
Maligna...